Skip to main content

Table 1 Description of the participants included in the study

From: The relationship between high-density lipoprotein cholesterol (HDL-C) and glycosylated hemoglobin in diabetic patients aged 20 or above: a cross-sectional study

Glycohemoglobin < 7
N = 2939
≥7
N = 232
All
N = 3171
P-value
Age (years) 46.27 ± 16.77 57.37 ± 13.53 46.86 ± 16.80 < 0.0001
ALT(U/L) 25.85 ± 46.66 33.63 ± 25.83 26.26 ± 45.83 0.0329
Cr (umol/L) 77.13 ± 29.41 77.96 ± 26.38 77.18 ± 29.26 0.7215
γGT (IU/L) 28.49 ± 40.77 44.17 ± 43.89 29.32 ± 41.09 < 0.0001
Glu (mg/dL) 93.54 ± 16.56 191.86 ± 70.91 98.73 ± 31.76 < 0.0001
sUA (mg/dL) 5.35 ± 1.46 5.39 ± 1.25 5.35 ± 1.45 0.7932
TG (mg/dL) 120.71 ± 85.30 187.58 ± 203.12 124.78 ± 97.97 < 0.0001
LDL (mg/dL) 116.11 ± 34.71 109.60 ± 37.31 115.74 ± 34.90 0.0945
TC (mg/dL) 195.14 ± 40.41 199.99 ± 77.05 195.39 ± 43.14 0.1563
HDL-C (mg/dL) 53.79 ± 16.25 44.84 ± 12.93 53.31 ± 16.22 < 0.0001
glycohemoglobin (%) 5.42 ± 0.43 8.53 ± 1.54 5.58 ± 0.89 < 0.0001
BMI (kg/m2) 28.20 ± 6.32 32.12 ± 7.28 28.42 ± 6.43 < 0.0001
Waist circumference (cm) 96.38 ± 14.98 108.57 ± 16.76 97.02 ± 15.32 < 0.0001
SBP (mmHg) 118.39 ± 16.41 118.62 ± 14.41 118.40 ± 16.31 0.8585
DBP (mmHg) 66.08 ± 13.28 64.75 ± 15.08 66.01 ± 13.39 0.2121
Sex(%)     0.0906
 Male 47.53 54.24 47.88  
 Female 52.47 45.76 52.12  
Race/ethnicity (%)     0.0598
 Mexican American 7.88 13.30 8.17  
 Other race/ethnicity 13.09 13.32 13.10  
 Non-Hispanic White 68.42 61.05 68.03  
 Non-Hispanic Black 10.61 12.33 10.70  
Age groups (%)     < 0.0001
 Age < 40 years 39.82 8.61 38.17  
 Age > =40, < 60 years 36.37 42.58 36.70  
 Age > =60 years 23.81 48.81 25.13  
Medications
 Lipid-lowering medications 74.17 33.23   < 0.0001
 Anti-diabetic medications 73.43 36.68   < 0.0001
  1. The continuous variables were characterized by mean ± standard and analyzed using a weighted linear regression model for continuous variables. The categorical variables were presented as percentages, and the p-value was calculated using a weighted chi-squared test.